UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | February 12, 2024 4:15 P.M. |
Form: | S-3 | |||||
|
Attachments
Disclaimer
Annovis Bio Inc. published this content on 12 February 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 February 2024 11:10:22 UTC.